Response Genetics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Response Genetics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8% to $18,040,000. Profit margin reached -112%. Total operating expenses were $25,319,000.

Profit Margin

Response Genetics, Inc (OTC:RGDXQ): Profit margin
2012 18.73M -7.75M -41.4%
2013 19.80M -7.47M -37.77%
2014 16.72M -13.53M -80.96%
2015 18.04M -20.18M -111.88%

RGDXQ Income Statement (2012 – 2015)

2015 2014 2013 2012
Revenue
Revenue
18.04M16.72M19.80M18.73M
Cost of revenue
14.09M10.01M10.45M10.41M
Gross profit
3.94M6.70M9.34M8.32M
Operating exp.
Research and development
5.48M1.72M1.60M2.12M
Selling and marketing
5.26M5.11M5.42M5.06M
Total operating expenses
25.31M19.71M17.29M15.97M
Operating income
-21.37M-13.00M-7.94M-7.65M
Other income (expenses), net
9K-691.77K-74.71K-99.81K
Income before tax
-21.36M-13.69M-8.02M-7.75M
Income tax expense
-1.18M-162.88K-541.13K0
Net income
-20.18M-13.53M-7.47M-7.75M
Earnings per share
Basic EPS
0-0.35-0.22-0.29
Diluted EPS
0-0.35-0.22-0.29